Ami Claxton, MS, PhD has joined Ionis Pharmaceuticals, Inc. as Director, Global HEOR Rare Disease Immunology. She will play a critical and significant role as…
Continue Reading →
The Chase Group is pleased to announce their continued partnership with Atsena Therapeutics after being retained to execute a search for an Associate Director/Director of…
Continue Reading →
As part of its growth strategy, Arcturus Therapeutics has partnered with The Chase Group to build and expand their vaccines development team. Founded in 2013…
Continue Reading →
Ionis Pharmaceuticals has a 30-year track record of perfecting and advancing RNA-targeted drug discovery and development and is now expanding its commercialization capabilities. That expansion…
Continue Reading →
After a comprehensive executive search that was completed in less than six weeks, The Chase Group is pleased to announce the placement of Dr. Molly…
Continue Reading →
Ventria Bioscience has partnered with The Chase Group to continue building its leadership team. The company’s technology is time-proven, with more than ten years of…
Continue Reading →
The Chase Group (TCG) is pleased to announce the successful recruitment of James Haney as the Vice President of Finance at Ionis Pharmaceuticals. Haney joins…
Continue Reading →
Alexza Pharmaceuticals continues to partner with The Chase Group to secure a Senior Director/Head, Quality Assurance. The Chase Group is currently seeking quality assurance professionals…
Continue Reading →
Atsena Therapeutics has retained The Chase Group to identify a Head of Regulatory. Chase is proud to partner with this clinical-stage ocular gene therapy company…
Continue Reading →
Ventria Bioscience has partnered once again with The Chase Group to continue building their leadership team as they develop and commercialize innovative medicines with an…
Continue Reading →